PDCD1 and neoplasm: TMB-H caused by MSI-H not only induces increased neoantigen expression and attracts more TILs, but also boosts PD-L1 expression, thus rendering tumor cells sensitive to PD-1/PD-L1 inhibitors (Chen, L et al., 2021).